UNSPSC 85782606: Supplement right lower leg with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right lower leg with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0YUH47Z

UNSPSC 85782606 Supplement right lower leg with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that does not align with the recent state and local contract opportunities identified under this code. The recent solicitations tagged to this code cover occupational medical surveillance, pharmacy benefit management, independent medical evaluation services for pension disability determinations, surgical procedure carve-out benefit programs, emergency and specialty medical services for detained youth, and temporary health professional staffing — none of which involve surgical tissue supplementation or orthopedic procedures using autologous grafting techniques. The mismatch suggests a data classification error or a misapplication of the code to opportunities that fall outside the surgical procedure scope the code nominally describes.

The issuing bodies across the records include state departments (Washington State Department of Transportation), county commissions and departments (Harris County Juvenile Probation, Collier County Board of County Commissioners), county health systems (County of Santa Clara Health System), municipal pension offices (City of Phoenix Retirement Office), and a municipal employment benefits program (City of Long Beach). Geographic activity appears concentrated in Arizona, California, Florida, Texas, and Washington. Without opportunities that actually match the orthopedic surgical scope of the code itself, the Commodity code shows little decision-relevant procurement activity for firms pursuing state and local work in autologous tissue supplementation or related surgical services.